MATTHEW PORTZ: Open Payments
NPI 1356364434 · BETHEL PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,056 in 110 payments from 24 companies in 2025. Trend: 2023 $1,699 · 2024 $2,292 · 2025 $2,056
Food & beverage: $2,056
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $431 |
| Novo Nordisk Inc | 16 | $274 |
| Lilly USA, LLC | 9 | $150 |
| Amgen Inc. | 9 | $143 |
| Agios Pharmaceuticals, Inc. | 5 | $122 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $106 |
| Lundbeck LLC | 4 | $101 |
| PFIZER INC. | 6 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
Products named: QULIPTA, REXULTI, JARDIANCE, UBRELVY, PYRUKYND, Wegovy, MOUNJARO, OTEZLA.
Industry payments across PA — which companies pay providers there.
